Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8
Closed -$5.94K 1668
2023
Q1
$5.94K Buy
+8
New +$896 ﹤0.01% 1626
2022
Q4
Sell
-8
Closed -$1K 1628
2022
Q3
$1K Hold
8
﹤0.01% 1605
2022
Q2
$1K Hold
8
﹤0.01% 1602
2022
Q1
$1K Buy
+8
New +$875 ﹤0.01% 1542
2015
Q4
Sell
-2,000
Closed -$2K 1770
2015
Q3
$2K Buy
+2,000
New +$44.6K ﹤0.01% 1774
2015
Q2
Sell
-1,200
Closed -$4K 2119
2015
Q1
$4K Hold
1,200
﹤0.01% 2022
2014
Q4
$2K Buy
+1,200
New +$14.7K ﹤0.01% 2079

Other funds holding DXCM

M&T Bank's DXCM Position: Q1 2026 in Review

M&T Bank reduced its DexCom (DXCM) stake by 13% in Q1 2026, selling an estimated $262K and leaving 25,627 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #676.

M&T Bank first reported a position in DXCM in Q3 2014 and has held it in 45 quarters since. The position peaked at $6.05M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • M&T Bank held 25,627 shares of DexCom worth $1.61M as of Q1 2026.
  • M&T Bank sold 3,756 DexCom shares in Q1 2026, an estimated $262K.
  • DexCom made up 0.01% of M&T Bank's portfolio in Q1 2026, its #676 holding.
  • M&T Bank first reported a position in DexCom in Q3 2014 and has held it in 45 quarters since.
  • M&T Bank's DexCom position peaked at $6.05M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.